Epstein-Barr virus-encoded BARF1 promotes proliferation of gastric carcinoma cells through regulation of NF-κB

Journal of Virology

Volumn 87, Issue 19, 2013, Pages 10515-10523

  Chang, Mee Soo ^a,b   Kim, Dong Ha ^c   Roh, Jin Kyung ^c   Middeldorp, Jaap M ^d   Kim, Yang Soo ^c,e   Kim, Sunghan ^c,e   Han, Seungbong ^e   Kim, Chul Woo ^b   Lee, Byung Lan ^b   Kim, Woo Ho ^b   Woo, Jun Hee ^e  

^a Seoul National University Boramae Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Asan Institute for Life Sciences   (South Korea)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; PROTEIN BARF1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BARF1 ONCOGENE; CANCER GROWTH; CANCER INHIBITION; CARCINOMA CELL; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CELLULAR SECRETION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; TUMOR GROWTH; TUMOR INVASION; UPREGULATION; VIRUS GENE;

APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EPSTEIN-BARR VIRUS INFECTIONS; FLUORESCENT ANTIBODY TECHNIQUE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOENZYME TECHNIQUES; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; VIRAL PROTEINS;

EID: 84886037179     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00955-13     Document Type: Article

References (44)

1. Epstein MA, Achong BG, Barr YM. 1964. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet i:702-703.
2. Kieff ED, Rickinson AB. 2007. Epstein-Barr virus and its replication, p 2603-2700. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
3. Raab-Traub N, Flynn K, Pearson G, Huang A, Levine P, Lanier A, Pagano J. 1987. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int. J. Cancer 39:25-29.
4. Burke AP, Yen TSB, Shekitka KM, Sobin LH. 1990. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod. Pathol. 3:377-380.
5. Lee JH, Kim SH, Han SH, An JS, Lee ES, Kim YS. 2009. Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis. J. Gastroenterol. Hepatol. 24:354-365.
6. Kang GH, Lee S, Kim WH, Lee HW, Kim JC, Rhyu MG, Ro JY. 2002. Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am. J. Pathol. 160:787-794.
7. Chang MS, Lee HS, Kim CW, Kim YI, Kim WH. 2001. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea. Pathol. Res. Pract. 197:395-400.
8. Jeong J-Y, Woo JH, Kim Y, Choi S, Lee SO, Kil S-R, Kim CW, Lee BL, Kim WH, Nam B-H, Chang MS. 2010. Nuclear factor-kappa B inhibition reduces markedly cell proliferation in Epstein-Barr virus-infected stomach cancer, but affects variably in Epstein-Barr virus-negative stomach cancer. Cancer Invest. 28:113-119.
9. Chang MS, Lee HS, Jung EJ, Kim CW, Lee BL, Kim WH. 2005. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas. Int. J. Oncol. 27:1265-1272.
10. van Beek J, zur Hausen A, Klein Kranenbarg E, van de Velde CJ, Middeldorp JM, van den Brule AJ, Meijer CJ, Bloemena E. 2004. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J. Clin. Oncol. 22:664-670.
11. Camargo MC, Murphy G, Koriyama C, Pfeiffer RM, Kim WH, Herrera-Goepfert R, Corvalan AH, Carrascal E, Abdirad A, Anwar M, Hao Z, Kattoor J, Yoshiwara-Wakabayashi E, Eizuru Y, Rabkin CS, Akiba S. 2011. Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis. Br. J. Cancer 105:38-43.
12. Lee HS, Chang MS, Yang HK, Lee BL, Kim WH. 2004. Epstein-Barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with Epstein-Barr virus-negative carcinoma. Clin. Cancer Res. 10:1698-1705.
13. Gewurz BE, Mar JC, Padi M, Zhao B, Shinners NP, Takasaki K, Bedoya E, Zou JY, Cahir-McFarland E, Quackenbush J, Kieff E. 2011. Canonical NF-κB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation. J. Virol. 85:6764-6773.
14. Kung C-P, Raab-Traub N. 2010. Epstein-Barr virus latent membrane protein 1 modulates distinctive NF-κB pathways through C-terminusactivating region 1 to regulate epidermal growth factor receptor expression. J. Virol. 84:6605-6614.
15. Song YJ, Kang MS. 2010. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation. Virus Genes 41:174-180.
16. Danve C, Decaussin G, Busson P, Ooka T. 2001. Growth transformation of primary epithelial cells with a NPC-derived Epstein-Barr virus strain. Virology 288:223-235.
17. Fiorini S, Ooka T. 2008. Secretion of Epstein-Barr virus-encoded BARF1 oncoprotein from latently infected B cells. Virol. J. 5:70. doi:10.1186/1743 -422X-5-70.
18. Sall A, Caserta S, Jolicoeur P, Franqueville L, de Turenne-Tessier M, Ooka T. 2004. Mitogenic activity of Epstein-Barr virus-encoded BARF1 protein. Oncogene 23:4938-4944.
19. Seto E, Ooka T, Middeldorp JM, Takada K. 2008. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity. Cancer Res. 68:1030-1036.
20. Sheng W, Decaussin G, Ligout A, Takada K, Ooka T. 2003. Malignant transformation of Epstein-Barr-virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus. J. Virol. 76:3859-3865.
21. Sheng W, Decaussin G, Sumner S, Ooka T. 2001. N-terminal domain of BARF1 gene encoded by Epstein-Barr virus is essential for malignant transformation of rodent fibroblasts and activation of Bcl-2. Oncogene 20:1176-1185.
22. Wang Q, Tsao SW, Ooka T, Nicolls JM, Cheung HW, Fu S, Wong YC, Wang X. 2006. Anti-apoptotic role of BARF1 in gastric cancer cells. Cancer Lett. 238:90-103.
23. Wei MX, de Turenne-Tessier M, Decaussin G, Benet G, Ooka T. 1997. Establishment of a monkey kidney epithelial cell line with the BARF1 open reading frame from Epstein-Barr virus. Oncogene 14:3073-3081.
24. Wei MX, Moulin JC, Decaussin G, Berger F, Ooka T. 1994. Expression and tumorigenicity of the Epstein-Barr virus BARF1 gene in human Louckes B-lymphocyte cell line. Cancer Res. 54:1843-1848.
25. Wei MX, Ooka T. 1989. A transforming function of the BARF1 gene encoded by Epstein-Barr virus. EMBO J. 8:2897-2903.
26. zur Hausen A, Brink AA, Craanen ME, Middeldorp JM, Meijer CJ, van den Brule AJ. 2000. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res. 60:2745-2748.
27. de Turenne-Tessier M, Jolicoeur P, Ooka T. 1997. Expression of the protein encoded by Epstein-Barr virus (EBV) BARF1 open reading frame from a recombinant adenovirus system. Virus Res. 52:73-85.
28. de Turenne-Tessier M, Jolicoeur P, Middeldorp JM, Ooka T. 2005. Expression and analysis of the Epstein-Barr virus BARF1-encoded protein from a tetracycline-regulatable adenovirus system. Virus Res. 109:9-18.
29. Strockbine LD, Cohen JI, Farrah T, Lyman SD, Wagener F, DuBose RF, Armitage RJ, Spriggs MK. 1998. The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J. Virol. 72:4015-4021.
30. Seto E, Yang L, Middeldorp JM, Sheen TS, Chen JY, Fukayama M, Eizuru Y, Ooka T, Takada K. 2005. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBVassociated gastric carcinoma tissues in the absence of lytic gene expression. J. Med. Virol. 76:82-88.
31. Wang L, Tam JP, Liu DX. 2006. Biochemical and functional characterization of Epstein-Barr virus-encoded BARF1 protein: interaction with human hTid1 protein facilitates its maturation and secretion. Oncogene 25:4320-4331.
32. Hoebe EK, Hutajulu SH, van Beek J, Stevens SJ, Paramita DK, Greijer AE, Middeldorp JM. 2011. Purified hexameric Epstein-Barr virusencoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients. Clin. Vaccine Immunol. 18:298-304.
33. Hoebe EK, Le Large TY, Tarbouriech N, Oosterhoff D, De Gruijl TD, Middeldorp JM, Greijer AE. 2012. Epstein-Barr virus-encoded BARF1 protein is a decoy receptor for macrophage colony stimulating factor and interferes with macrophage differentiation and activation. Viral Immunol. 25:461-470.
34. Hoebe EK, Wille C, Hopmans ES, Robinson AR, Middeldorp JM, Kenney SC, Greijer AE. 2012. Epstein-Barr virus transcription activator R upregulates BARF1 expression by direct binding to its promoter, independent of methylation. J. Virol. 86:11322-11332.
35. Shim AH, Chang RA, Chen X, Longnecker R, He X. 2012. Multipronged attenuation of macrophage-colony stimulating factor signaling by Epstein-Barr virus BARF1. Proc. Natl. Acad. Sci. U.S.A. 109:12962-12967.
36. Karin M. 2006. Nuclear factor-κB in cancer development and progression. Nature 441:431-436.
37. Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M. 1999. NF-κB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol. Cell. Biol. 19:2690-2698.
38. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387-400.
39. Sakka E, Hausen AZ, Houali K, Liu H, Fiorini S, Ooka T. 2013. Cellular localization of BARF1 oncoprotein and its cell stimulating activity in human epithelial cell. Virus Res. 174:8-17.
40. Wiech T, Nikolopoulos E, Lassman S, Heidt T, Schöpflin A, Sarbia M, Werner M, Shimizu Y, Sakka E, Ooka T, zur Hausen A. 2008. Cyclin D1 expression is induced by viral BARF1 and is overexpressed in EBVassociated gastric cancer. Virchows Arch. 452:621-627.
41. Jung KW, Park S, Won YJ, Kong HJ, Lee JY, Seo HG, Lee JS. 2012. Prediction of cancer incidence and mortality in Korea. Cancer Res. Treat. 44:25-31.
42. Udhayakumar G, Jayanthi V, Devaraj N, Devaraj H. 2007. Interaction of MUC1 with beta-catenin modulates the Wnt target gene cyclin D1 in H. pylori-induced gastric cancer. Mol. Carcinog. 46:807-817.
43. Kim B, Byun SJ, Kim YA, Kim JE, Lee BL, Kim WH, Chang MS. 2010. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas. Pathology 42:58-65.
44. Oh JH, Ban JO, Cho M-C, Jo M, Jung JK, Ahn B, Yoon D-Y, Han SB, Hong JT. 2012. 4-O-Methylhonokiol inhibits colon tumor growth via p21-mediated suppression of NF-κB activity. J. Nutr. Biochem. 23:706-715.